Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

2nd GOP debate takeaways
‘America is going full Joker’
Uber names new CFO
Clinton taunts Putin
Birthday celebration moved
Attacks Biden over EVs
Passes formal dress code
Is the news racist?
Pilot error killed billionaire
To host reality show spinoff
Drug-test welfare recipients?
Apologizes for tribute to vet
Tech CEO murder suspect
Released in error, captured
FAA ends Blue Origin probe
Out of US Open Cup final
Philippe strengthens
Cardin replaces Menendez
Diamondbacks cut Davies
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
147,000 results
5hon MSN
FDA panel overwhelmingly votes against experimental ALS treatment pushed by patients
Federal health advisors voted 17-1 against an experimental treatment for Lou Gehrig's disease dubbed NurOwn, although the FDA ...
WISH-TV
3h
Health Spotlight: First FDA-approved drug to slow Alzheimer’s
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...
6h
FDA advisers vote against experimental ALS therapy pushed by patients
In the last year, the FDA has approved two new drugs for ALS, after a nearly 20-year drought of new options. The approvals ...
13hon MSN
Health Headlines: FDA approves Alzheimer treatment
CLEVELAND, Ohio (Ivanhoe Newswire) – More than six million Americans are living with Alzheimer’s disease, it slowly steals ...
ENDPOINTS NEWS
8h
Ad­comm rec­om­mends FDA re­ject Brain­Stor­m's ALS drug af­ter com­pa­ny filed over protest
A panel of independent experts on Wednesday recommended the FDA reject an experimental ALS drug developed by the biotech BrainStorm Cell Therapeutics, marking another defeat for the long embattled ...
7don MSN
Medical Moment: FDA approves first-ever drug to slow Alzheimer’s
There is no cure yet, but now, a newly FDA-approved drug is helping to slow its progression before it’s too late.
朝日新聞社9d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 JST Share Tweet list Print This image provided by Eisai in January 2023 shows vials and packaging for ...
Sentinel Colorado
1d
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
"FDA is the 800-pound gorilla here and if they're convinced that the drug doesn't work it's very hard to change their minds," ...
1don MSN
After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Washington Examiner26d
FDA needs to let go of its risk-averse regulatory model
The FDA also gave full approval to a drug called Leqembi, which slowed Alzheimer’s patients’ functional and cognitive decline by 27% over 18 months, according to trial data.
WPLG
3h
FDA advisers vote against experimental ALS treatment pushed by patients
Federal health advisers have voted overwhelmingly against recommending approval of an experimental treatment for Lou Gehrig's ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices